The clinical trial did not assess ERA in a recurrent implantation failure (RIF) patient population and therefore cannot comment on the utility of ERA for this particular group of patients. However, patients with RIF represent only a very small fraction of all IVF patients. “It is important to emphasize that we cannot assess the benefit of ERA for patients with recurrent implantation failure,”
Read More